Document is current
Any future updates will be listed below
-
Authors
Ma, Teng
Huang, Rongrong
Xu, Yanhua
Lv, Yangbo
Liu, Yifan
Pan, Xin
Dong, Jia
Gao, Di
Wang, Zeyu
Zhang, Fenglei
Yan, Chunxi
Ong, Sang-Bing
Su, Yang
Xu, Dachun https://orcid.org/0000-0002-4123-6613
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03727828 at ClinicalTrials.govDocuments that mention this clinical trial
Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial
https://doi.org/10.1186/s12967-022-03859-w
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81770391)
Shanghai Hospital Development Center (SHDC2020CR3030B)
- License Information
-
More Information
Article History
Received: 29 July 2022
Accepted: 28 December 2022
First Online: 12 January 2023
Declarations
:
: The studies involving human participants were reviewed and approved by Approval No. 22KN261 of Shanghai Tenth Hospital. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
